cilengitide has been researched along with 2-furoyl-ligrlo-amide in 1 studies
| Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (2-furoyl-ligrlo-amide) | Trials (2-furoyl-ligrlo-amide) | Recent Studies (post-2010) (2-furoyl-ligrlo-amide) |
|---|---|---|---|---|---|
| 194 | 29 | 133 | 56 | 0 | 41 |
| Protein | Taxonomy | cilengitide (IC50) | 2-furoyl-ligrlo-amide (IC50) |
|---|---|---|---|
| Proteinase-activated receptor 2 | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dockendorff, C; Gandhi, DM; Hernandez, I; Holyst, T; Majewski, MW; Rosas, R; Wang, Z; Weiler, H; Zhu, J | 1 |
1 other study(ies) available for cilengitide and 2-furoyl-ligrlo-amide
| Article | Year |
|---|---|
Synthesis and initial pharmacology of dual-targeting ligands for putative complexes of integrin αVβ3 and PAR2.
Topics: | 2020 |